NCT04560283View on ClinicalTrials.gov

HYDEAL-D® Application for Promoting the Restoration of Sexual Function in the Postpartum Period

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

May 1, 2020

Study Completion Date

September 1, 2020

Conditions
Vagina; AnomalyPuerperium; DiseaseSexual Dysfunction
Interventions
DRUG

Vaginal gel HYALOGYN®

Vaginal gel HYALOGYN® (HYDEAL-D® 2%; Fidia Farmaceutici, Abano Terme, Italy) every 3 days up for 12 consecutive weeks

BEHAVIORAL

Expectant management

Expectant management for 12 consecutive weeks

Trial Locations (1)

Unknown

Ospedale Policlinico San Martino, Genova

All Listed Sponsors
lead

Ospedale Policlinico San Martino

OTHER

NCT04560283 - HYDEAL-D® Application for Promoting the Restoration of Sexual Function in the Postpartum Period | Biotech Hunter | Biotech Hunter